---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-011786"
form_type: "8-K"
ticker: "NVCT"
cik: "0001875558"
company_name: "Nuvectis Pharma, Inc."
filed_at: "2022-02-04T23:59:59+00:00"
generated_at: "2026-06-27T11:15:23.621535+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuvectis Pharma prices $16M underwritten offering of 3.2M shares at $5.00; effects 39-for-1 stock split

## Summary
- Gross proceeds of $16M from sale of 3.2M shares at $5.00; expected close Feb 8, 2022.
- 39-for-1 stock split effective Feb 3, 2022; shares begin trading split-adjusted Feb 4, 2022.
- Authorized common stock increased to 60M shares; authorized preferred stock at 5M shares.
- Underwriting agreement with H.C. Wainwright & Co. as representative of underwriters.

## SEC filing metadata
- accession: 0001104659-22-011786
- form_type: 8-K
- ticker: NVCT
- cik: 0001875558
- company_name: Nuvectis Pharma, Inc.
- filed_at: 2022-02-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1875558/000110465922011786/0001104659-22-011786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1875558/000110465922011786/tm2134227d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-011786
- JSON: https://secwatch.observer/filing/0001104659-22-011786.json
- Plain text: https://secwatch.observer/filing/0001104659-22-011786.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.